Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion
Gespeichert in:
| Veröffentlicht in: | Haematologica (Roma) 2003-12, Vol.88 (12), p.1423-1425 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1425 |
|---|---|
| container_issue | 12 |
| container_start_page | 1423 |
| container_title | Haematologica (Roma) |
| container_volume | 88 |
| creator | Kattamis, Antonis Kassou, Christina Berdousi, Helen Ladis, Vasilis Papassotiriou, Ioannis Kattamis, Christos |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71474609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71474609</sourcerecordid><originalsourceid>FETCH-LOGICAL-p207t-36bfcb812b20644400a9a3baf3b5438901205d940dfced24a060512a751e896b3</originalsourceid><addsrcrecordid>eNo1kE9LxDAQxYMg7rr6FSQnb4UkTZvGmxT_wYIXPZekmbCRNqlJirvf3oDraZg3v_d4zAXa0kayqhOMbtB1Sl-EMCKluEIbyttOSNltUejDrJ0Hg_MBolpO-MflAzaQLMTowlHN5YqVN0UrkltiKLvzhVeTSglmN-JFZQc-pwcM1sKYcfB4jc6reMKuGDAcxwjZBX-DLq2aEtye5w59Pj999K_V_v3lrX_cVwsjIld1q-2oO8o0Iy3nnBAlVa2VrXXD604SykhjJCfGjmAYV6QlDWVKNBQ62ep6h-7_ckvf7xVSHmaXRpgm5SGsaRCUC94SWcC7M7jqGcywRDeX2sP_i-pf1Ddjjg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71474609</pqid></control><display><type>article</type><title>Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><creator>Kattamis, Antonis ; Kassou, Christina ; Berdousi, Helen ; Ladis, Vasilis ; Papassotiriou, Ioannis ; Kattamis, Christos</creator><creatorcontrib>Kattamis, Antonis ; Kassou, Christina ; Berdousi, Helen ; Ladis, Vasilis ; Papassotiriou, Ioannis ; Kattamis, Christos</creatorcontrib><identifier>EISSN: 1592-8721</identifier><identifier>PMID: 14687998</identifier><language>eng</language><publisher>Italy</publisher><subject>Adolescent ; Adult ; beta-Thalassemia - surgery ; beta-Thalassemia - therapy ; beta-Thalassemia - urine ; Chelation Therapy ; Combined Modality Therapy ; Deferoxamine - administration & dosage ; Deferoxamine - pharmacokinetics ; Deferoxamine - therapeutic use ; Drug Therapy, Combination ; Female ; Humans ; Iron - urine ; Iron Chelating Agents - administration & dosage ; Iron Chelating Agents - pharmacokinetics ; Iron Chelating Agents - therapeutic use ; Iron Overload - drug therapy ; Iron Overload - etiology ; Iron Overload - urine ; Male ; Pyridones - administration & dosage ; Pyridones - pharmacokinetics ; Pyridones - therapeutic use ; Splenectomy ; Tissue Distribution ; Transfusion Reaction ; Treatment Outcome</subject><ispartof>Haematologica (Roma), 2003-12, Vol.88 (12), p.1423-1425</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14687998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kattamis, Antonis</creatorcontrib><creatorcontrib>Kassou, Christina</creatorcontrib><creatorcontrib>Berdousi, Helen</creatorcontrib><creatorcontrib>Ladis, Vasilis</creatorcontrib><creatorcontrib>Papassotiriou, Ioannis</creatorcontrib><creatorcontrib>Kattamis, Christos</creatorcontrib><title>Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion</title><title>Haematologica (Roma)</title><addtitle>Haematologica</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>beta-Thalassemia - surgery</subject><subject>beta-Thalassemia - therapy</subject><subject>beta-Thalassemia - urine</subject><subject>Chelation Therapy</subject><subject>Combined Modality Therapy</subject><subject>Deferoxamine - administration & dosage</subject><subject>Deferoxamine - pharmacokinetics</subject><subject>Deferoxamine - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Humans</subject><subject>Iron - urine</subject><subject>Iron Chelating Agents - administration & dosage</subject><subject>Iron Chelating Agents - pharmacokinetics</subject><subject>Iron Chelating Agents - therapeutic use</subject><subject>Iron Overload - drug therapy</subject><subject>Iron Overload - etiology</subject><subject>Iron Overload - urine</subject><subject>Male</subject><subject>Pyridones - administration & dosage</subject><subject>Pyridones - pharmacokinetics</subject><subject>Pyridones - therapeutic use</subject><subject>Splenectomy</subject><subject>Tissue Distribution</subject><subject>Transfusion Reaction</subject><subject>Treatment Outcome</subject><issn>1592-8721</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE9LxDAQxYMg7rr6FSQnb4UkTZvGmxT_wYIXPZekmbCRNqlJirvf3oDraZg3v_d4zAXa0kayqhOMbtB1Sl-EMCKluEIbyttOSNltUejDrJ0Hg_MBolpO-MflAzaQLMTowlHN5YqVN0UrkltiKLvzhVeTSglmN-JFZQc-pwcM1sKYcfB4jc6reMKuGDAcxwjZBX-DLq2aEtye5w59Pj999K_V_v3lrX_cVwsjIld1q-2oO8o0Iy3nnBAlVa2VrXXD604SykhjJCfGjmAYV6QlDWVKNBQ62ep6h-7_ckvf7xVSHmaXRpgm5SGsaRCUC94SWcC7M7jqGcywRDeX2sP_i-pf1Ddjjg</recordid><startdate>200312</startdate><enddate>200312</enddate><creator>Kattamis, Antonis</creator><creator>Kassou, Christina</creator><creator>Berdousi, Helen</creator><creator>Ladis, Vasilis</creator><creator>Papassotiriou, Ioannis</creator><creator>Kattamis, Christos</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200312</creationdate><title>Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion</title><author>Kattamis, Antonis ; Kassou, Christina ; Berdousi, Helen ; Ladis, Vasilis ; Papassotiriou, Ioannis ; Kattamis, Christos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p207t-36bfcb812b20644400a9a3baf3b5438901205d940dfced24a060512a751e896b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>beta-Thalassemia - surgery</topic><topic>beta-Thalassemia - therapy</topic><topic>beta-Thalassemia - urine</topic><topic>Chelation Therapy</topic><topic>Combined Modality Therapy</topic><topic>Deferoxamine - administration & dosage</topic><topic>Deferoxamine - pharmacokinetics</topic><topic>Deferoxamine - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Humans</topic><topic>Iron - urine</topic><topic>Iron Chelating Agents - administration & dosage</topic><topic>Iron Chelating Agents - pharmacokinetics</topic><topic>Iron Chelating Agents - therapeutic use</topic><topic>Iron Overload - drug therapy</topic><topic>Iron Overload - etiology</topic><topic>Iron Overload - urine</topic><topic>Male</topic><topic>Pyridones - administration & dosage</topic><topic>Pyridones - pharmacokinetics</topic><topic>Pyridones - therapeutic use</topic><topic>Splenectomy</topic><topic>Tissue Distribution</topic><topic>Transfusion Reaction</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kattamis, Antonis</creatorcontrib><creatorcontrib>Kassou, Christina</creatorcontrib><creatorcontrib>Berdousi, Helen</creatorcontrib><creatorcontrib>Ladis, Vasilis</creatorcontrib><creatorcontrib>Papassotiriou, Ioannis</creatorcontrib><creatorcontrib>Kattamis, Christos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Haematologica (Roma)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kattamis, Antonis</au><au>Kassou, Christina</au><au>Berdousi, Helen</au><au>Ladis, Vasilis</au><au>Papassotiriou, Ioannis</au><au>Kattamis, Christos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion</atitle><jtitle>Haematologica (Roma)</jtitle><addtitle>Haematologica</addtitle><date>2003-12</date><risdate>2003</risdate><volume>88</volume><issue>12</issue><spage>1423</spage><epage>1425</epage><pages>1423-1425</pages><eissn>1592-8721</eissn><cop>Italy</cop><pmid>14687998</pmid><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1592-8721 |
| ispartof | Haematologica (Roma), 2003-12, Vol.88 (12), p.1423-1425 |
| issn | 1592-8721 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71474609 |
| source | MEDLINE; DOAJ Directory of Open Access Journals |
| subjects | Adolescent Adult beta-Thalassemia - surgery beta-Thalassemia - therapy beta-Thalassemia - urine Chelation Therapy Combined Modality Therapy Deferoxamine - administration & dosage Deferoxamine - pharmacokinetics Deferoxamine - therapeutic use Drug Therapy, Combination Female Humans Iron - urine Iron Chelating Agents - administration & dosage Iron Chelating Agents - pharmacokinetics Iron Chelating Agents - therapeutic use Iron Overload - drug therapy Iron Overload - etiology Iron Overload - urine Male Pyridones - administration & dosage Pyridones - pharmacokinetics Pyridones - therapeutic use Splenectomy Tissue Distribution Transfusion Reaction Treatment Outcome |
| title | Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T09%3A45%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20therapy%20with%20desferrioxamine%20and%20deferiprone%20in%20thalassemic%20patients:%20effect%20on%20urinary%20iron%20excretion&rft.jtitle=Haematologica%20(Roma)&rft.au=Kattamis,%20Antonis&rft.date=2003-12&rft.volume=88&rft.issue=12&rft.spage=1423&rft.epage=1425&rft.pages=1423-1425&rft.eissn=1592-8721&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71474609%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71474609&rft_id=info:pmid/14687998&rfr_iscdi=true |